secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001104659-24-085391
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences special meeting fails due to lack of quorum; warrant approval deferred
--------------------------------------------------------------------------------

- Special meeting on Aug 2, 2024 had 4,056,202 shares present, below required majority; adjourned without action.
- Proposal sought stockholder approval to exercise Series A and B warrants from May 2024 public offering.
- Without approval, company must call a subsequent meeting to seek warrant stockholder approval.
- Series Warrants remain unexercisable until Nasdaq-required shareholder approval is obtained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/0001104659-24-085391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/tm2420716d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-085391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer